Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who are Overweight or Obese (SURMOUNT-2)

In by ECIR

Locations
Macon
Condition
Diabetes, Obese/Obesity

Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who are Overweight or Obese (SURMOUNT-2)

  • Hidden
  • This field is for validation purposes and should be left unchanged.
clinicaltrials.gov

Eligibility

Inclusion Criteria
  1. Male or Female ≥ 18 years of age
  2. T2DM
  3. BMI ≥ 27 kg/m2
  4. A1c 7-10%
Exclusion Criteria
  1. T1DM or any other type of DM other than T2DM
  2. Treatment with a GLP-1 RA, DPP-4 inhibitor, or any injectable therapy for DM
Back to Current Studies